1. Home
  2. SDGR vs GRDN Comparison

SDGR vs GRDN Comparison

Compare SDGR & GRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • GRDN
  • Stock Information
  • Founded
  • SDGR 1990
  • GRDN 2004
  • Country
  • SDGR United States
  • GRDN United States
  • Employees
  • SDGR N/A
  • GRDN N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • GRDN Retail-Drug Stores and Proprietary Stores
  • Sector
  • SDGR Health Care
  • GRDN Consumer Staples
  • Exchange
  • SDGR Nasdaq
  • GRDN Nasdaq
  • Market Cap
  • SDGR 1.7B
  • GRDN 1.6B
  • IPO Year
  • SDGR 2020
  • GRDN 2024
  • Fundamental
  • Price
  • SDGR $21.62
  • GRDN $21.24
  • Analyst Decision
  • SDGR Buy
  • GRDN Strong Buy
  • Analyst Count
  • SDGR 5
  • GRDN 2
  • Target Price
  • SDGR $32.80
  • GRDN $24.50
  • AVG Volume (30 Days)
  • SDGR 1.2M
  • GRDN 308.2K
  • Earning Date
  • SDGR 05-07-2025
  • GRDN 05-12-2025
  • Dividend Yield
  • SDGR N/A
  • GRDN N/A
  • EPS Growth
  • SDGR N/A
  • GRDN N/A
  • EPS
  • SDGR N/A
  • GRDN N/A
  • Revenue
  • SDGR $230,492,000.00
  • GRDN $1,282,307,000.00
  • Revenue This Year
  • SDGR $24.71
  • GRDN $11.69
  • Revenue Next Year
  • SDGR $17.64
  • GRDN $2.55
  • P/E Ratio
  • SDGR N/A
  • GRDN N/A
  • Revenue Growth
  • SDGR 22.29
  • GRDN 19.55
  • 52 Week Low
  • SDGR $16.60
  • GRDN $14.16
  • 52 Week High
  • SDGR $28.47
  • GRDN $26.91
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 41.07
  • GRDN N/A
  • Support Level
  • SDGR $21.13
  • GRDN N/A
  • Resistance Level
  • SDGR $22.00
  • GRDN N/A
  • Average True Range (ATR)
  • SDGR 1.03
  • GRDN 0.00
  • MACD
  • SDGR -0.23
  • GRDN 0.00
  • Stochastic Oscillator
  • SDGR 30.11
  • GRDN 0.00

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About GRDN Guardian Pharmacy Services Inc. Class A Common Stock

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.

Share on Social Networks: